UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$191M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$157M |
| 3 |
Pfizer
PFE
|
+$139M |
| 4 |
3M
MMM
|
+$131M |
| 5 |
Meta Platforms (Facebook)
META
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altera Corp
ALTR
|
+$288M |
| 2 |
Intercontinental Exchange
ICE
|
+$247M |
| 3 |
RKT
ROCK-TENN COMPANY CL-A
RKT
|
+$142M |
| 4 |
Yelp
YELP
|
+$140M |
| 5 |
Salesforce
CRM
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.28% |
| 2 | Financials | 14.69% |
| 3 | Technology | 14.25% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Eagle Bancorp
EGBN
$861M
| $431K | ﹤0.01% |
9,800
+2,600
| +36% | +$104K |
|
2077
EXL Service
EXLS
$5.11B
| $429K | ﹤0.01% |
62,000
+11,500
| +23% | +$79.9K |
|
2078
Red Robin
RRGB
$151M
| $429K | ﹤0.01% |
5,000
+100
| +2% | +$8.24K |
|
|
CCMP
2079
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $429K | ﹤0.01% |
9,100
+600
| +7% | +$28.7K |
|
|
ADPT
2080
DELISTED
Adeptus Health Inc
ADPT
| $429K | ﹤0.01% |
+4,516
| New | +$311K |
|
|
CFNL
2081
DELISTED
Cardinal Financial Corp
CFNL
| $429K | ﹤0.01% |
19,698
+3,600
| +22% | +$75K |
|
|
ISCA
2082
DELISTED
International Speedway Corp
ISCA
| $427K | ﹤0.01% |
11,652
+1,453
| +14% | +$53.4K |
|
2083
BioCryst Pharmaceuticals
BCRX
$2.31B
| $426K | ﹤0.01% |
28,500
+2,400
| +9% | +$27.3K |
|
2084
Materion
MTRN
$6.18B
| $426K | ﹤0.01% |
12,099
| – | – |
|
2085
Quanex
NX
$959M
| $426K | ﹤0.01% |
19,898
+1,600
| +9% | +$30.8K |
|
|
ADAM
2086
Adamas Trust
ADAM
$848M
| $425K | ﹤0.01% |
14,199
+925
| +7% | +$29K |
|
|
STAY
2087
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $424K | ﹤0.01% |
22,600
+4,100
| +22% | +$81.1K |
|
|
ORIT
2088
DELISTED
Oritani Financial Corp. New
ORIT
| $424K | ﹤0.01% |
26,398
+4,500
| +21% | +$68K |
|
|
MTGE
2089
DELISTED
MTGE Investment Corp. Common Stock
MTGE
| $424K | ﹤0.01% |
26,498
+5,000
| +23% | +$87.7K |
|
2090
Greenlight Captial
GLRE
$522M
| $423K | ﹤0.01% |
14,499
+2,500
| +21% | +$76.3K |
|
|
ELNK
2091
DELISTED
EarthLink Holdings Corp.
ELNK
| $421K | ﹤0.01% |
56,196
+2,000
| +4% | +$12.1K |
|
|
XOOM
2092
DELISTED
XOOM CORP COM
XOOM
| $421K | ﹤0.01% |
20,000
+700
| +4% | +$13K |
|
|
DMND
2093
DELISTED
DIAMOND FOODS, INC.
DMND
| $420K | ﹤0.01% |
13,399
+900
| +7% | +$27.4K |
|
2094
ESCO Technologies
ESE
$8.49B
| $419K | ﹤0.01% |
11,200
| – | – |
|
2095
Greif
GEF
$5.12B
| $419K | ﹤0.01% |
11,699
-7,326
| -39% | -$291K |
|
|
GSIG
2096
DELISTED
GSI GROUP INC COM STK (CDA)
GSIG
| $419K | ﹤0.01% |
27,898
| – | – |
|
|
BSFT
2097
DELISTED
BroadSoft, Inc.
BSFT
| $418K | ﹤0.01% |
12,099
+2,200
| +22% | +$78K |
|
|
TDAY
2098
USA Today Co
TDAY
$1.27B
| $417K | ﹤0.01% |
23,282
+4,500
| +24% | +$96K |
|
|
CBPX
2099
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
| $417K | ﹤0.01% |
19,700
+9,700
| +97% | +$218K |
|
2100
Movado Group
MOV
$867M
| $416K | ﹤0.01% |
15,302
+2,100
| +16% | +$60.5K |
|
Similar funds
UBS AM's Q2 2015 Portfolio in Review
As of Q2 2015, UBS AM held 2,771 positions worth $104B, up 0.68% from $104B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2015 filing shows 148 new, 1,779 increased, 566 reduced and 77 closed positions. Its largest new stake was Viatris: 1,260,214 shares worth $85.5M. The largest sale was Altera Corp, an estimated $288M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Financials and Technology.
- UBS AM's largest Q2 2015 buy was Viatris: 1,260,214 shares worth $85.5M.
- UBS AM added most to Allergan plc in Q2 2015, an estimated $191M increase.
- UBS AM's biggest Q2 2015 reduction was Altera Corp, cutting an estimated $288M.
- UBS AM fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $78.3M.
- UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q2 2015.
- UBS AM opened 148 new positions and closed 77 in Q2 2015.
- UBS AM's portfolio value rose 0.68% quarter-over-quarter to $104B.
Based on UBS AM's 13F filing for Q2 2015, filed 12 Aug 2015.